Desmoplastic Melanoma: A Clinicopathological Analysis of Three Cases in the Chinese Population

References

• Conlev J, Lattes R, Orr W. Desmoplastic malignant melanoma (A rare variant of spindle cell melanoma). Cancer. 1971;28(4):914–936. doi:10.1002/1097-0142(1971)28:4<914::AID-CNCR2820280415>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Frydenlund N, Mahalingam M. Desmoplastic melanoma, neurotropism, and neurotrophin receptors—what we know and what we do not. Adv Anat Pathol. 2015;22(4):227–241. doi:10.1097/PAP.0000000000000076
   PubMed Web of Science ®Google Scholar
• Zhuang Feng Z, Wu X, Chen V, Velie E, Zhang Z. Incidence and survival of desmoplastic melanoma in the United States, 1992–2007. J Cutan Pathol. 2011;38(8):616–624. doi:10.1111/j.1600-0560.2011.01704.x
   PubMed Web of Science ®Google Scholar
• Xu Z, Yibulayin F, Shi P, Feng L. Desmoplastic melanoma versus spindle cell melanoma: incidence and survival, 1973 to 2017. Medicine (Baltimore). 2018;97(29):e11563. doi:10.1097/MD.0000000000011563
   PubMedGoogle Scholar
• DeWane ME, Kelsey A, Oliviero M, Rabinovitz H, Grant-Kels JM. Melanoma on chronically sun-damaged skin: lentigo maligna and desmoplastic melanoma. J Am Acad Dermatol. 2019;81(3):823–833. doi:10.1016/j.jaad.2019.03.066
   PubMed Web of Science ®Google Scholar
• Labrecque PG, Hu CH, Winkelmann RK. On the nature of desmoplastic melanoma. Cancer. 2015;38(3):1205–1213. doi:10.1002/1097-0142(197609)38:3<1205::AID-CNCR2820380322>3.0.CO;2-K
   Google Scholar
• Busam KJ, Mujumdar U, Hummer AJ, et al. Cutaneous desmoplastic melanoma. Am J Surg Pathol. 2004;28(11):1518–1525. doi:10.1097/01.pas.0000141391.91677.a4
   PubMed Web of Science ®Google Scholar
• Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol. 2015;152(4):673–678. doi:10.1111/j.1365-2133.2005.06462.x
   Google Scholar
• Kooper-Johnson S, Mahalingam M, Loo DS. SOX-10 and S100 negative desmoplastic melanoma: apropos a diagnostically challenging case. Am J Dermatopathol. 2020;1.
   Google Scholar
• Suo Z, Nesland JM. Electron microscopy in diagnosis of spindle cell tumors. Semin Diagn Pathol. 2003;20(1):5–12.
   PubMed Web of Science ®Google Scholar
• Nicolson NG, Han D. Desmoplastic melanoma. J Surg Oncol. 2019;119(2):208–215. doi:10.1002/jso.25317
   PubMed Web of Science ®Google Scholar
• Busam JK. Cutaneous desmoplastic melanoma. Adv Anat Pathol. 2005;12(2):92. doi:10.1097/01.pap.0000155071.86944.a6
   PubMed Web of Science ®Google Scholar
• Chen LL, Jaimes N, Barker CA, Busam KJ, Marghoob AA. Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68(5):825–833. doi:10.1016/j.jaad.2012.10.041
   PubMed Web of Science ®Google Scholar
• Jain S, Allen PW. Desmoplastic malignant melanoma and its variants. A study of 45 cases. Am J Surg Pathol. 1989;13(5):358–373. doi:10.1097/00000478-198905000-00003
   PubMed Web of Science ®Google Scholar
• Rabbie R, Ferguson P, Molina-Aguilar C, Adams DJ, Robles-Espinoza CD. Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities. J Pathol. 2019;247(5):539–551. doi:10.1002/path.5213
   PubMed Web of Science ®Google Scholar
• Ochoa CE, Joseph RW. Desmoplastic melanoma: a brief review and the efficacy of immunotherapy. Expert Rev Anticancer Ther. 2019;19(3):205–207. doi:10.1080/14737140.2019.1574573
   PubMed Web of Science ®Google Scholar
• Han D, Han G, Zhao X, et al. Clinicopathologic predictors of survival in patients with desmoplastic melanoma. PLoS One. 2015;10(3):e0119716. doi:10.1371/journal.pone.0119716
   PubMed Web of Science ®Google Scholar
• De Almeida LS, Requena L, Rütten A, et al. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases. Am J Dermatopathol. 2008;30(3):207–215. doi:10.1097/DAD.0b013e3181716e6b
   PubMed Web of Science ®Google Scholar
• Plaza JA, Bonneau P, Prieto V, et al. Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis. J Cutan Pathol. 2016;43(4):313–323. doi:10.1111/cup.12654
   PubMed Web of Science ®Google Scholar
• Serra S, Chetty R. p16. J Clin Pathol. 2018;71(10):853–858. doi:10.1136/jclinpath-2018-205216
   PubMed Web of Science ®Google Scholar
• Elsensohn A, Shiu J, Grove N, Hosking AM, Barr R, de Feraudy S. Distinguishing neurofibroma from desmoplastic melanoma: the value of p53. Am J Surg Pathol. 2018;42(3):372–375. doi:10.1097/PAS.0000000000000978
   PubMed Web of Science ®Google Scholar
• Morey AL, Murali R, Mccarthy SW, et al. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology. 2009;41(4):383–387. doi:10.1080/00313020902915875
   PubMed Web of Science ®Google Scholar
• Lai Y, Wu Y, Liu R, et al. Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus. Diagn Pathol. 2020;15(1). doi:10.1186/s13000-020-00937-9.
   Web of Science ®Google Scholar
• Chen JY, Hruby G, Scolyer RA, et al. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer. 2008;113(10):2770. doi:10.1002/cncr.23895
   PubMed Web of Science ®Google Scholar
• Smithers BM, Mcleod GR, Little JH. Desmoplastic melanoma: patterns of recurrence. World J Surg. 1992;16(2):186–190. doi:10.1007/BF02071519
   PubMed Web of Science ®Google Scholar
• Gershenwald JE, Scolyer RA. Melanoma staging: American Joint Committee on Cancer (AJCC) 8th Edition and beyond. Ann Surg Oncol. 2018;25(8):2105–2110. doi:10.1245/s10434-018-6513-7
   PubMed Web of Science ®Google Scholar
• Oliver DE, Patel KR, Switchenko J. Comparing survival outcomes in early stage desmoplastic melanoma with or without adjuvant radiation. Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma Res. 2016;26(1):35–41. doi:10.1097/CMR.0000000000000201
   PubMed Web of Science ®Google Scholar
• Abbott JL, Qureshi MM, Truong MT, et al. Comparing survival outcomes in early stage desmoplastic melanoma with or without adjuvant radiation. Melanoma Res. 2019;29(4):413–419. doi:10.1097/CMR.0000000000000532
   PubMed Web of Science ®Google Scholar
• Guadagnolo BA, Prieto V, Weber R, Ross MI, Zagars GK. The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer. 2014;120(9):1361–1368. doi:10.1002/cncr.28415
   PubMed Web of Science ®Google Scholar
• Murali R, Shaw HM, Lai K, et al. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Cancer. 2010;116(17):4130–4138. doi:10.1002/cncr.25148
   PubMed Web of Science ®Google Scholar
• Fung MA, Sharon VR, Ratnarathorn M, Konia TH, Barr KL, Mirmirani P. Elastin staining patterns in primary cicatricial alopecia. J Am Acad Dermatol. 2013;69(5):776–782. doi:10.1016/j.jaad.2013.07.018
   PubMed Web of Science ®Google Scholar
• Hay JL, Christian SN. Skin cancer screening. Psycho-Oncology. 2021.
   Google Scholar
• Calonje E, Fletcher CDM. Aneurysmal benign fibrous histiocytoma: clinicopathological analysis of 40 cases of a tumour frequently misdiagnosed as a vascular neoplasm. Histopathology. 2010;26(4):323–331. doi:10.1111/j.1365-2559.1995.tb00193.x
   Google Scholar
• Yang Y, Yang F, Zhu Y, et al. Desmoplastic melanoma involving head and fingers: diagnostic challenges and clinical characteristics. Int J Clin Exp Pathol. 2019;12(10):3862–3869.
   PubMed Web of Science ®Google Scholar
• Najem A, Krayem M, Sales F, et al. P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition. Eur J Cancer. 2017;83:154–165. doi:10.1016/j.ejca.2017.06.033
   PubMed Web of Science ®Google Scholar
• Shain AH, Garrido M, Botton T, et al. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015;47(10):1194–1199. doi:10.1038/ng.3382
   PubMed Web of Science ®Google Scholar
• Young RJ, Waldeck K, Martin C, et al. Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines. Pigment Cell Melanoma Res. 2014;27(4):590–600. doi:10.1111/pcmr.12228
   PubMed Web of Science ®Google Scholar
• Livestro DP, Muzikansky A, Kaine EM. Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol. 2005;23(27):6739–6746. doi:10.1200/JCO.2005.04.515
   PubMed Web of Science ®Google Scholar
• Han D, Zager JS, Yu D, Zhao X, Walls B. Desmoplastic melanoma: is there a role for sentinel lymph node biopsy? Ann Surg Oncol. 2013;20(7):2345–2351. doi:10.1245/s10434-013-2883-z
   PubMed Web of Science ®Google Scholar
• Shi P, Xu Z, Lei X, et al. Desmoplastic melanoma: demographic and clinicopathological features and disease-specific prognostic factors. Oncol Lett. 2019;17(6):5619–5627. doi:10.3892/ol.2019.10259
   PubMed Web of Science ®Google Scholar
• Debarbieux S, Ronger-Salve S, Dalle S, Balme B, Thomas L. Dermoscopy of desmoplastic melanoma: report of six cases. Br J Dermatol. 2008;159(2):360–363. doi:10.1111/j.1365-2133.2008.08687.x
   PubMed Web of Science ®Google Scholar